Established risk loci for systemic lupus erythematosus at NCF2, STAT4, TNPO3, IRF5 and ITGAM associate with distinct clinical manifestations: A Danish genome-wide association study

DBDS Genomic Consortium

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number105357
Pages (from-to)105357
JournalJoint Bone Spine
Volume89
Issue number4
DOIs
Publication statusPublished - 1 Feb 2022

Bibliographical note

Funding Information:
Supported by grants from the Danish Rheumatism Association (non-commercial) to HCB Leffers (A5094) and S Jacobsen (A3865). D Westergaard, S Brunak and K Banasik were supported by grants from the Novo Nordisk Foundation (NNF17OC0027594, NNF14CC0001, and NNF18SA0034956).

Funding Information:
The authors would like to thank all the SLE patients participating in the project. The authors would like to thank the national The Danish Rheumatologic Database (DANBIO), Denmark. The authors would also like to thank the Danish Rheumatologic Biobank (DRB). The authors would also like to thank the Danish Blood Donor Study (DBDS).

Other keywords

  • Clinical phenotype
  • Disease manifestations
  • Genome wide association study
  • GWAS
  • Lupus Nephritis
  • SLE
  • Systemic Lupus Erythematosus
  • NADPH Oxidases
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • beta Karyopherins
  • Humans
  • CD11b Antigen/genetics
  • Lupus Erythematosus, Systemic/genetics
  • Case-Control Studies
  • Denmark/epidemiology
  • Interferon Regulatory Factors/genetics
  • STAT4 Transcription Factor
  • Polymorphism, Single Nucleotide

Cite this